NOS3 and type 2 diabetes mellitus: Global hypermethylation in pre-diabetic and treatment naïve T2D individuals compared to controls while no significant difference observed in global DNA methylation between individuals with T2D on treatment and those with normoglycaemia. NOS3 G894T polymorphism an independent determinant of global DNA methylation.